The prevalence of diagnosed ?1-antitrypsin deficiency and its comorbidities: results from a large population-based database Source: Eur Respir J 2017; 49(1): 1600154; DOI: 10.1183/13993003.00154-2016 Year: 2017
Alpha-1-antitrypsin deficiency patients (AATD): two-year follow-up Source: Eur Respir J 2002; 20: Suppl. 38, 260s Year: 2002
Risk of cancer in individuals with severe alpha-1-antitrypsin deficiency (PiZZ) compared with the Swedish general population Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement? Year: 2020
The influence of metabolic syndrome in mortality rate of COPD patients: A five years follow up study Source: Annual Congress 2012 - COPD comorbidities II Year: 2012
Prevalence of alpha1-antitrypsin deficiency and its influence on lung function decline in patients with severe asthma Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020
Inflammatory biomarkers are associated with aetiology and predict outcomes in community-acquired pneumonia: results of a 5-year follow-up cohort study Source: ERJ Open Res, 5 (1) 00014-2019; 10.1183/23120541.00014-2019 Year: 2019
Long-term effects of severe acute malnutrition on lung function in Malawian children: a cohort study Source: Eur Respir J , 49 (4) 1601301; DOI: 10.1183/13993003.01301-2016 Year: 2017
Description of the COPD patients free of suffering severe exacerbations. Ten-year follow up of a cohort Source: Virtual Congress 2020 – Monitoring of patients with COPD Year: 2020
Incidence of alpha-1-antitrypsin (α1-AT) deficiency in patients with COPD in Poland, preliminary report Source: Eur Respir J 2005; 26: Suppl. 49, 440s Year: 2005
Differences in the disease phenotype and comorbidities between patients with COPD and alpha-1-antitrypsin deficiency - An analysis of the COSYCONET cohort Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016
Increased mortality in patients with corticosteroid-dependent asthma: a nationwide population-based study Source: Eur Respir J, 54 (5) 1900804; 10.1183/13993003.00804-2019 Year: 2019
Alpha1-antitrypsin deficiency: An analysis of patient subgroups of the German registry Source: Annual Congress 2011 - COPD mechanisms Year: 2011
Iron deficiency and lung function decline in stable COPD – a prospective cohort study Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020
Mortality in individuals with severe alpha-1-antitrypsin deficiency (PiZZ) Source: Eur Respir J 2006; 28: Suppl. 50, 144s Year: 2006
Does vitamin D deficiency worsen the hospital outcome in patients with acute exacerbation COPD? Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD Year: 2018
Quality of life evaluation in patients with alpha1-antitripsin deficiency: A 3-year prospectic study Source: Annual Congress 2011 - What do individuals know about their disease? Educational needs, the psychological impact of chronic respiratory disease and health-related quality of life Year: 2011
Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study Source: Eur Respir J, 55 (5) 2000524; 10.1183/13993003.00524-2020 Year: 2020
Genotyping and phenotyping of alpha1-antitrypsin deficiency Greek patients under augmentation therapy: a multicenter study Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020
Survival in individuals with severe alpha 1-antitrypsin deficiency (PiZZ) in comparison to a general population with known smoking habits Source: Eur Respir J, 50 (3) 1700198; 10.1183/13993003.00198-2017 Year: 2017
Genotype alone does not predict the clinical course of SFTPC deficiency in paediatric patients Source: Eur Respir J 2015; 46: 197-206 Year: 2015